HopeStage
Back to all studies
CompletedNCT04190004

Vasopressin and Cooperative Behavior in Schizophrenia

About this titleRead the official source — NCT04190004
Medication studyAges 18–45India
The study in practice

Understand this study

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 45 years. Other eligibility criteria applied.

Listed locations
BangaloreSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: January 1, 2018
Recruitment status
Completed
Enrollment listed in the registry
30
Sponsor
National Institute of Mental Health and Neuro Sciences, India
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Locations
India
Age range
From 18 Years to 45 Years
Official registry ID
NCT04190004
Official title
Show the full official title

Effect of Intranasal Vasopressin on Cooperative Behavior in Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Bangalore

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute of Mental Health and Neuro Sciences, India, a research institute.

Did this study involve medication?

Yes. The study involved medication, including Vasopressins and Placebo.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 45 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies